Status:
UNKNOWN
Lateral Neck Lymph Node Mapping in Thyroid Cancer
Lead Sponsor:
Fudan University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
14-80 years
Phase:
NA
Brief Summary
This study includes papillary thyroid cancer patients who have unpalpable lateral neck lymph nodes but suspicious on ultrasound and/or CT. Carbon nanoparticles is used as the tracer for lateral neck l...
Eligibility Criteria
Inclusion
- Newly diagnosed papillary thyroid cancer
- The maximum diameter of the thyroid cancer \<3 cm with enough normal thyroid tissue for tracer injection
- Unpalpable lateral neck lymph nodes
- Ultrasound and CT showed suspected lateral neck lymph nodes \<2 cm
Exclusion
- Previously treated thyroid cancer
- High risk thyroid cancer (e.g. with severe extra-adenial invasion or extensive lymph node metastasis or poorly differentiated thyroid cancer)
- Patients with distant metastasis
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04312087
Start Date
August 1 2016
End Date
December 31 2022
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, China, 200032